US$ 21.33
bpc-157 fda approved drug status reviews regulatory of peptides FDA Peptide Reclassification 2026: What
Description
Who is a candidate and who is not

Injection likely remains preferable if you are treating specific local injuries and want maximum peptide concentration at the injury site
Its application to allergic disease specifically relies partly on extrapolation from its known mechanisms (Treg support, Th1/Th2 rebalancing), which are directly relevant to allergy pathophysiology

Thymosin 4/TB-500 in cell migration and tissue remodelling